🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 713317105
- IPO
- 5/6/2022 · $12.00/share
Business: PepGen Inc. is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. PepGen’s Enhanced Deliver Oligonucleotide, or EDO, platform is founded on over a decade of research and development and leverages cell-penetrating peptides to improve the uptake and activity of conjugated oligonucleotide therapeutics.
Company Contact
- CEO
- James McArthur
- CFO
- Noel Donnelly
- Headquarters
- 321 Harrison Ave. 8th Floor, Boston, MA 02118
- Phone
- 781-797-0979
- Investor Relations
- Laurence Watts, Gilmartin Group · Laurence@gilmartinir.com